Predicting factors associated with prolonged intensive care unit stay of patients with COVID-19

Background Predicting the length of stay (LOS) for coronavirus disease 2019 (COVID-19) patients in the intensive care unit (ICU) is essential for efficient use of ICU resources. We analyzed the clinical characteristics of patients with severe COVID-19 based on their clinical care and determined the predictive factors associated with prolonged LOS. Methods We included 96 COVID-19 patients who received oxygen therapy at a high-flow nasal cannula level or above after ICU admission during March 2021 to February 2022. The demographic characteristics at the time of ICU admission and results of severity analysis (Sequential Organ Failure Assessment [SOFA], Acute Physiology and Chronic Health Evaluation [APACHE] II), blood tests, and ICU treatments were analyzed using a logistic regression model. Additionally, blood tests (C-reactive protein, D-dimer, and the PaO2 to FiO2 ratio [P/F ratio]) were performed on days 3 and 5 of ICU admission to identify factors associated with prolonged LOS. Results Univariable analyses showed statistically significant results for SOFA score at the time of ICU admission, C-reactive protein level, high-dose steroids, mechanical ventilation (MV) care, continuous renal replacement therapy, extracorporeal membrane oxygenation, and prone position. Multivariable analysis showed that MV care and P/F ratio on hospital day 5 were independent factors for prolonged ICU LOS. For D-dimer, no significant variation was observed at admission; however, after days 3 and 5 days of admission, significant between-group variation was detected. Conclusions MV care and P/F ratio on hospital day 5 are independent factors that can predict prolonged LOS for COVID-19 patients.

[1]  K. Zendehdel,et al.  Mortality Predictive Value of APACHE II and SOFA Scores in COVID-19 Patients in the Intensive Care Unit , 2022, Canadian respiratory journal.

[2]  A. Baek,et al.  Lower Driving Pressure and Neuromuscular Blocker Use Are Associated With Decreased Mortality in Patients With COVID-19 ARDS , 2021, Respiratory Care.

[3]  S. Vollmer,et al.  The association between mechanical ventilator compatible bed occupancy and mortality risk in intensive care patients with COVID-19: a national retrospective cohort study , 2021, BMC Medicine.

[4]  P. Palange,et al.  Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: A pilot prospective study , 2021, European Journal of Internal Medicine.

[5]  M. Rech,et al.  Sedation Usage in COVID-19 Acute Respiratory Distress Syndrome: A Multicenter Study , 2021, The Annals of pharmacotherapy.

[6]  G. Natalini,et al.  COVID-19 ARDS Is Characterized by Increased Dead Space Ventilation Compared With Non-COVID ARDS , 2021, Respiratory Care.

[7]  D. Bravata,et al.  Association of Intensive Care Unit Patient Load and Demand With Mortality Rates in US Department of Veterans Affairs Hospitals During the COVID-19 Pandemic , 2021, JAMA network open.

[8]  S. Jordan,et al.  Tocilizumab for Covid-19 — The Ongoing Search for Effective Therapies , 2020, The New England journal of medicine.

[9]  M. Mckenney,et al.  A Closer Look Into Global Hospital Beds Capacity and Resource Shortages During the COVID-19 Pandemic , 2020, Journal of Surgical Research.

[10]  H. Mansouritorghabeh,et al.  D-dimer level in COVID-19 infection: a systematic review , 2020, Expert review of hematology.

[11]  Ankur Khajuria,et al.  The effect of smoking on COVID‐19 severity: A systematic review and meta‐analysis , 2020, Journal of medical virology.

[12]  Rishi Banerjee,et al.  Hospital Mortality and Resource Implications of Hospitalisation with COVID-19 in London, UK: A Prospective Cohort Study , 2020, medRxiv.

[13]  Toshiaki Iba,et al.  The unique characteristics of COVID-19 coagulopathy , 2020, Critical Care.

[14]  A. Gawande,et al.  How South Korea Responded to the Covid-19 Outbreak in Daegu , 2020, Nejm Catalyst Innovations in Care Delivery.

[15]  M. Elhadi,et al.  Concerns for low-resource countries, with under-prepared intensive care units, facing the COVID-19 pandemic , 2020, Infection, Disease & Health.

[16]  Sook-In Jung,et al.  Age-Related Morbidity and Mortality among Patients with COVID-19 , 2020, Infection & chemotherapy.

[17]  Jin-Min Yuan,et al.  Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis , 2020, International Journal of Public Health.

[18]  Wei Li,et al.  The value of clinical parameters in predicting the severity of COVID‐19 , 2020, Journal of medical virology.

[19]  Xu Li,et al.  Acute respiratory failure in COVID-19: is it “typical” ARDS? , 2020, Critical Care.

[20]  J. Choi COVID-19 in South Korea , 2020, Postgraduate Medical Journal.

[21]  R. Braren,et al.  Intensive Care Risk Estimation in COVID-19 Pneumonia Based on Clinical and Imaging Parameters: Experiences from the Munich Cohort , 2020, medRxiv.

[22]  Jian-Ping Liu,et al.  The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients , 2020, International Immunopharmacology.

[23]  Giuseppe Citerio,et al.  Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) , 2020, Intensive Care Medicine.

[24]  W. Ko,et al.  Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status , 2020, International Journal of Antimicrobial Agents.

[25]  Yuxin Shi,et al.  Clinical progression of patients with COVID-19 in Shanghai, China , 2020, Journal of Infection.

[26]  Yazdan Yazdanpanah,et al.  Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists , 2020, Intensive Care Medicine.

[27]  Y. Cho,et al.  Clinical Practice Guideline of Acute Respiratory Distress Syndrome , 2016, Tuberculosis and respiratory diseases.

[28]  G. Rubenfeld,et al.  Global Variability in Reported Mortality for Critical Illness during the 2009-10 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Regression to Guide Reporting of Outcomes during Disease Outbreaks , 2016, PloS one.

[29]  A. Malhotra,et al.  The Effect of Steroid Dosing on Risk of Secondary Infection in COVID-19 Critically Ill Patients , 2021, TP91. TP091 EPIDEMIOLOGY AND TRANSLATIONAL ADVANCES IN SARS-COV-2.

[30]  SEPSIS BULLETIN,et al.  Surviving Sepsis Campaign : Guidelines on the Management of Critically Ill Adults with Coronavirus Disease , 2020 .